Loading...

Ipsen S.A.

IPSEY•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$50.60
$1.52(3.10%)
U.S. Market opens in 7h 39m

Ipsen S.A. (IPSEY) Stock Overview

Explore Ipsen S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap66.9B
P/E Ratio32.43
EPS (TTM)$1.56
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$44.34
3 Months$46.57
1 Year Target$38.88

IPSEY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ipsen S.A. (IPSEY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 75.15, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $38.88.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 32.43 and a market capitalization of 66.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.10%
5-Day Change
3.08%
1-Month Change
4.24%
3-Month Change
27.49%
6-Month Change
40.24%
Year-to-Date (YTD) Change
39.16%
1-Year Change
70.66%
3-Year Change
68.27%
5-Year Change
111.009%
All-Time (Max) Change
471.75%

Contact Information

https://www.ipsen.com
33 1 58 33 50 00
65 Quai Georges Gorse, Boulogne-Billancourt, NaN, 92100

Company Facts

5,358 Employees
IPO DateAug 3, 2012
CountryFR
Actively Trading

Frequently Asked Questions